The efficacy of Intravenous magnesium sulfate on bleeding through orthognathic surgery
Phase 2
- Conditions
- Bimaxillary Orthognathic Surgery.00
- Registration Number
- IRCT201311051674N9
- Lead Sponsor
- Vice-Chancellery of Research and Technology, Shiraz University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with no history of systemic disease and without taking any analgesic medications criteria that were willing to cooperate in this study were enrolled; and Exclusion criteria included known allergy to the study drugs; hepatic and renal dysfunction ; patients with heart block or myocardial damage; morbid obesity (BMI = 35); neuromuscular disease; history of neuropathy; asthma; use of calcium channel blockers and Patients who did not sign the informed consent.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bleeding during surgery. Timepoint: During operation and postoperative. Method of measurement: CC.
- Secondary Outcome Measures
Name Time Method se of blood products. Timepoint: Postoperative. Method of measurement: CC.;Side effects of magnesium sulfate. Timepoint: Intraoperative. Method of measurement: Hemodynamic changes.